1. Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials
- Author
-
Basir, Mir B, Pinto, Duane S, Ziaeian, Boback, Khandelwal, Akshay, Cowger, Jennifer, Suh, William, and Althouse, Andrew
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Trials and Supportive Activities ,Cardiovascular ,Clinical Research ,Heart Disease ,Heart Disease - Coronary Heart Disease ,Heart-Assist Devices ,Humans ,Intra-Aortic Balloon Pumping ,Myocardial Infarction ,Randomized Controlled Trials as Topic ,Shock ,Cardiogenic ,Treatment Outcome ,United States ,acute myocardial infarction ,STEMI ,cardiogenic shock ,clinical trials ,ECMO ,IABP ,Tandem ,Impella ,mechanical circulatory support ,ECMO/IABP/Tandem/Impella ,acute myocardial infarction/STEMI ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundAcute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is associated with significant morbidity and mortality.MethodsWe provide an overview of previously conducted studies on the use of mechanical circulatory support (MCS) devices in the treatment of AMI-CS and difficulties which may be encountered in conducting such trials in the United States.ResultsWell powered randomized control trials are difficult to conduct in a critically ill patient population due to physician preferences, perceived lack of equipoise and challenges obtaining informed consent.ConclusionsWith growth in utilization of MCS devices in patients with AMI-CS, efforts to perform well-powered, randomized control trials must be undertaken.
- Published
- 2021